Scarica l'app Stockscreener
65.80
2.96%
1.89
Precedente Chiudi:
$63.91
Aprire:
$64.16
Volume 24 ore:
525.64K
Relative Volume:
0.88
Capitalizzazione di mercato:
$3.59B
Reddito:
$1.35B
Utile/perdita netta:
$-217.48M
Rapporto P/E:
-16.41
EPS:
-4.0106
Flusso di cassa netto:
$191.43M
1 W Prestazione:
-1.14%
1M Prestazione:
+7.29%
6M Prestazione:
+24.01%
1 anno Prestazione:
+38.18%
Intervallo 1D:
$63.58
$66.61
Intervallo di 1 settimana:
$62.91
$67.42
Portata 52W:
$32.48
$67.92
Livanova Plc Stock (LIVN) Company Profile
Nome
Livanova Plc
Settore
Industria
Telefono
4402033250662
Indirizzo
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
65.80 | 3.49B | 1.35B | -217.48M | 191.43M | -4.0106 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-19 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | Downgrade | Goldman | Buy → Neutral |
| 2025-05-20 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | Iniziato | Goldman | Buy |
| 2024-09-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Reiterato | Needham | Buy |
| 2024-02-20 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-09-06 | Iniziato | HSBC Securities | Hold |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-04-14 | Iniziato | Mizuho | Neutral |
| 2022-12-21 | Iniziato | Barclays | Equal Weight |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-02-24 | Aggiornamento | UBS | Neutral → Buy |
| 2021-12-03 | Iniziato | Goldman | Buy |
| 2021-08-20 | Reiterato | Needham | Buy |
| 2021-07-20 | Aggiornamento | Needham | Hold → Buy |
| 2021-03-03 | Downgrade | Berenberg | Buy → Hold |
| 2021-01-05 | Downgrade | Needham | Buy → Hold |
| 2020-09-02 | Iniziato | Robert W. Baird | Outperform |
| 2020-06-26 | Reiterato | Needham | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-02-28 | Reiterato | Needham | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-06-08 | Iniziato | Stifel | Buy |
| 2018-05-31 | Reiterato | Needham | Buy |
| 2018-02-28 | Reiterato | Needham | Buy |
Mostra tutto
Livanova Plc Borsa (LIVN) Ultime notizie
LSV Asset Management Raises Stake in LivaNova PLC $LIVN - MarketBeat
Is LivaNova PLC subject to activist investor interest2025 Historical Comparison & Fast Entry High Yield Tips - mfd.ru
What margin trends mean for LivaNova PLC stockWeekly Trade Summary & AI Based Buy/Sell Signal Reports - mfd.ru
Aug Ideas: Does LivaNova PLC stock benefit from AI growthJuly 2025 Technicals & Growth Focused Entry Point Reports - baoquankhu1.vn
Can LivaNova PLC outperform in the next rallyJuly 2025 Short Interest & Smart Money Movement Tracker - mfd.ru
Allianz Asset Management GmbH Makes New $7.69 Million Investment in LivaNova PLC $LIVN - MarketBeat
LivaNova to present at JP Morgan Healthcare Conference in January - MSN
New York State Common Retirement Fund Acquires 93,267 Shares of LivaNova PLC $LIVN - MarketBeat
Bioelectric Medicine Market is expected to reach US$ 235.55 - openPR.com
LivaNova PLC (LIVN) Stock Analysis: Promising 9.35% Upside as Healthcare Innovator Surges - DirectorsTalk Interviews
Responsive Playbooks and the LIVN Inflection - Stock Traders Daily
A Look At LivaNova (LIVN) Valuation After KeyBanc Upgrade And Renewed Medtech Optimism - Sahm
LivaNova Stock Checks Its Pulse: Can LIVN’s Recent Slide Set Up A Recovery Rally? - AD HOC NEWS
LivaNova PLC (NASDAQ:LIVN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
What LivaNova (LIVN)'s KeyBanc Upgrade and Medtech Reassessment Means For Shareholders - simplywall.st
LivaNova stock reaches 52-week high at $65.95 By Investing.com - Investing.com Australia
LivaNova (LIVN) Upgraded to Overweight by KeyBanc - Finviz
What are KeyBanc’s Top MedTech Picks By Investing.com - Investing.com Nigeria
What are KeyBanc’s Top MedTech Picks - Investing.com
LivaNova (NASDAQ:LIVN) Sets New 1-Year HighHere's What Happened - MarketBeat
LivaNova stock reaches 52-week high at $65.95 - Investing.com
Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up - Yahoo Finance
From Humanoid Robots to AI Seating: VivaNova Debuts "Active Health" Tech at imm cologne 2026 - GlobeNewswire Inc.
Understanding the Setup: (LIVN) and Scalable Risk - Stock Traders Daily
Autotransfusion System Market is expected to reach US$ 1,094.30 - openPR.com
Emerald Mutual Fund Advisers Trust Purchases 26,202 Shares of LivaNova PLC $LIVN - MarketBeat
Cardiac Pacemaker Market Covering Prime Factors - openPR.com
SG Americas Securities LLC Reduces Stake in LivaNova PLC $LIVN - MarketBeat
Assessing LivaNova (LIVN) Valuation As Shares Track Recent Momentum And Ongoing Losses - simplywall.st
These 4 Measures Indicate That LivaNova (NASDAQ:LIVN) Is Using Debt Safely - 富途资讯
Extracorporeal Membrane Oxygenation (ECMO) Machines Market - openPR.com
LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results - marketscreener.com
Should I buy LivaNova PLC (LIA) stock before earnings seasonEarnings Volatility Patterns & Small Investment Portfolio - bollywoodhelpline.com
Medical Implants Market Is Booming So Rapidly Growth by 2033 |Biotronik, Inc., Livanova Plc, NuVasive - openPR.com
Are Options Traders Betting on a Big Move in LivaNova Stock? - MSN
What risks investors should watch in LivaNova PLC stockEconomic Indicators Overview & Top Analyst Picks Available for Free - bollywoodhelpline.com
Wall Street Recap: Can LivaNova PLC maintain sales growth2025 Market Overview & Growth Oriented Trading Recommendations - baoquankhu1.vn
LivaNova (NASDAQ:LIVN) Stock Price Crosses Above 50 Day Moving AverageTime to Sell? - MarketBeat
Aug Chart Watch: Whats the fair value of LivaNova PLC stock2025 Growth vs Value & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Deep Brain Stimulation Devices Market Valuation Set to Achieve - openPR.com
LivaNova Announces Chief Legal Officer Resignation and Succession - The Globe and Mail
LivaNova chief legal officer Michael Hutchinson resigns; search for successor begins By Investing.com - Investing.com South Africa
LivaNova chief legal officer Michael Hutchinson resigns; search for successor begins - Investing.com UK
Does LivaNova PLC have strong fundamentalsEarnings Risk Report & Free Weekly Chart Analysis and Trade Guides - bollywoodhelpline.com
Market Trends: Does LivaNova PLC have pricing powerInsider Selling & Weekly Watchlist of Top Performers - baoquankhu1.vn
Macro Review: Is LivaNova PLC stock attractive for income investorsPortfolio Performance Summary & High Accuracy Investment Entry Signals - Bộ Nội Vụ
Extracorporeal Membrane Oxygenation Machine Market Size to Hit USD 725.99 Million by 2033, Growing at a CAGR of 4.91% - GlobeNewswire Inc.
LivaNova PLC (LIVN) Stock Analysis: Exploring a 17% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews
The Technical Signals Behind (LIVN) That Institutions Follow - Stock Traders Daily
LivaNova (LIVN) Is Up 6.2% After Fresh Analyst Optimism on Advanced Therapies PortfolioWhat's Changed - Sahm
Is LivaNova PLC stock a dividend growth opportunityPortfolio Gains Report & Growth Oriented Trade Recommendations - Улправда
Livanova Plc Azioni (LIVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Livanova Plc Azioni (LIVN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| PODLOGAR SUSAN M | Director |
Dec 15 '25 |
Option Exercise |
0.00 |
2,355 |
0 |
2,355 |
| Hutchinson Michael Damon | SVP, CLO and Company Secretary |
Dec 15 '25 |
Option Exercise |
0.00 |
2,254 |
0 |
7,920 |
| Story Brooke | Director |
Nov 18 '25 |
Sale |
53.94 |
250 |
13,485 |
6,232 |
1.33%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):